Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

Publication date: Available online 12 February 2021Source: CellAuthor(s): Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, Adam L. Bailey, Rita E. Chen, Zhenlu Chong, Seth J. Zost, Hyesun Jang, Ying Huang, James D. Allen, James Brett Case, Rachel E. Sutton, Robert H. Carnahan, Tamarand L. Darling, Adrianus C.M. Boon, Matthias Mack, Richard D. Head, Ted M. Ross, James E. Crowe, Michael S. Diamond

Source: Cell - February 14, 2021 Category: Cytology Source Type: research